In the past 5 years, important advances have been made in the scientific understanding and
clinical management of cholangiocarcinoma (CCA). The cellular immune landscape of CCA …

Objective: To systematically review studies reporting survival data following neoadjuvant
chemoradiation and orthotopic liver transplantation (NCR-OLT) for unresectable perihilar …

Intrahepatic cholangiocarcinoma (iCCA) is a rare biliary tract cancer with high mortality rate.
Complete resection of the iCCA lesion is the first choice of treatment, with good prognosis …

These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

Background. Intrahepatic cholangiocarcinoma (iCCA) is a contraindication to liver
transplantation in most centers worldwide. Therefore, only a few such cases have been …

Conclusions: Liver transplantation for TO indications has adequate 5-years survival rates,
mostly when performed under the selection criteria available in literature (Mayo-like …

abstract Intrahepatic cholangiocarcinoma (iCCA) is a rare biliary tract cancer with high
mortality rate. Complete resection of the iCCA lesion is the first choice of treatment, with …

Because many patients are diagnosed with iCCA at later stages, tumor biology and genetics
are useful tools to identify patients who will have excellent overall and recurrence-free …

Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver
transplantation, even ruling out an active waiting list registration. However, recent studies …

Organ shortage requires policies and guidelines to aid organ allocation along the principles
of urgency or utility. Identifying patients with significant benefit and withholding liver …